Blu Genes Foundation gives UMMS $1.4M to bring Tay-Sachs gene therapy to clinical trial
The Toronto-based Blu Genes Foundation, which is dedicated to developing gene therapies for rare disease, has given $1.4 million to UMass Medical School to advance a Phase I/II clinical trial for Tay-Sachs. Miguel Sena-Esteves, PhD, Terence Flotte, MD, Heather Gray-Edwards, PhD, DVM, and colleagues at Auburn University are leading the research.Read more
- Blu Genes Foundation gives UMMS $1.4M to bring Tay-Sachs gene therapy to clinical trial
- Robert Brown Jr. and Jonathan Watts honored by Angel Fund for ALS
- UMass Medical School scientists safely deliver RNAi-based gene therapy for ALS in animal model
- Silvia Corvera, Michael Czech receive $2.5M grant to advance potential therapy for type 2 diabetes
- Postdoc Tessa Simone explores role of immune cells in cancer
Women in Science
Raziel Rojas-Rodriguez, a PhD candidate in the Program in Molecular Medicine, is studying how adipose tissue expansion during pregnancy is related to metabolic health. Learn more about her research in this Women in Science video.
Student AccomplishmentsRead more!
Student Interviews on LabTV
Find out what GSBS students are curious about! View Graduate Student LabTV Interviews.